Delphyr, founded in 2023, is an AI-driven platform poised to revolutionize healthcare analytics. As a pioneer in the AI and Healthtech sectors, the company is based in The Netherlands.
With the slogan, "Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians," the platform is designed to streamline data analytics, optimizing time management for healthcare professionals while enhancing patient outcomes and minimizing hospital expenditures.
Delphyr recently secured a €1.75M angel investment on 01 March 2026, with backing from notable investors such as Gijs Nagel and Thomas Wolf. This funding milestone underscores strong confidence in Delphyr's vision and potential for transformative impact in medical data processing.
The company's cutting-edge technology positions it strategically at the intersection of healthcare and artificial intelligence, making it an attractive opportunity for further investment and growth within these dynamic industries.